Share This

Topics Comments

Cheung Kong VODone Limited Shenzhen International Holdings Limited Jiangxi Copper Company Limited REXLot Holdings Limited China Overseas Land & Investment Limited Chong Hing Bank Limited Agricultural Bank of China Limited Chow Tai Fook Jewellery Group Limited Capital VC Limited iShares A50 Standard Chartered Bank of Communications Bank of China China LotSynergy Holdings Limited agribank Agri Airlines Appl AUD Auto A Shares Brokers CAD fertilizer producers China Lottery Supermarket China Banks Communication Consumer China Econ Electricity China Finance China IT Petro Real Est China Resource Steel coal Commodity Beauty Drugs Enviro EURO Lang Simon Ting WongSir Andy Xie Expo Gambling Garment gas GBD Gold Gold Jew Gold mine Harbour Highways HK Apparel REITs Rentals HK Banks ETF HK Housing Market Real Est HK HK Stock iBond Infra Insure IPO jewel Mach Build Mat New Energy NZD Oil Paper Rare Earths Real Estate Market Food RMB Rising RMB RMB Bonds Shipbuilding Shipping Sports Stock Trend Taiwan Dollar (TWD) Textile Top 500 USD US Econ Util Water Yang Liu's 10 Stocks YEN Diary media Central Bank Monetary Policy Education Construction Emerging markets Nuclear power BillGross Cement HK retail logistics Swiss franc Social Security Fund Law Ka-Chung capital flow Financial and political policy Railway film Korean Won Roubini Faber Mobius
Topics Last reply time Nickname Content
MicroPort Scientific Corporation 2022-01-14T09:45 財經茄呢啡 微創醫療(0853)冠脈支架產品本來是微創醫療最賺錢的業務,受到集中採購政策影響,集團去年上半年虧損逾9000萬美元,集團首10個月冠脈支架在全球累計訂單量與發貨量雙雙突破100萬件,未來5年更擬大幅增加相關產能。
MicroPort Scientific Corporation 2021-09-10T11:02 財經茄呢啡 微創旗下已上市子公司心脈醫療(滬:688016)及心通醫療下半年以來股價分別急跌42.2%及52.8%,作為母公司的微創估值受壓。
MicroPort Scientific Corporation 2021-09-10T11:02 財經茄呢啡 由於2月成功分拆心通醫療(2160)集資3.6億美元,6月亦發行可換股債券集資7億美元,微創醫療(0853)累計引入外部融資10.6億美元,故即使期內錄得近億美元虧損,今年6月底股東權益反而較去年底增加30.5%至14.72億美元。
MicroPort Scientific Corporation 2021-09-10T11:02 財經茄呢啡 受惠全國冠脈支架集中帶量採購,微創醫療(0853)心血管介入產品業務銷量大幅上升,惟由於每單位售價大跌,收入下跌24.3%至6683萬美元,利潤更急挫76.7%至784萬美元。
MicroPort Scientific Corporation 2021-09-10T11:02 財經茄呢啡 微創大股東是日本大塚製藥,在中國人口老化將為醫療器械帶來龐大需求的過程中,微創可望汲取日本的經驗及技術將業務做大做強。
MicroPort Scientific Corporation 2020-08-24T20:02 財經茄呢啡 微創醫療(0853)將於下周一(31日)日收市後,成為MSCI明晟環球指數系列香港指數成份股。中央鼓勵內地醫療器械市場以國產取代入口產品,為本土醫療企業帶來長期增長機會。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.